insights_auto
Why is SBS up 4,04%?
Dive Deeperchevron_right
SBS:FRA
Stratec SE
23,15 €
arrow_upward
+4,04%(+0,90) 1D
13 հոկ, 08:05:31 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SBS...
Open
23,15 €
High
23,15 €
Low
23,15 €
Mkt. cap
288,18 մլն
Avg. vol.
51,00
Volume
0,00
Dividend
2,59%
Quarterly dividend
0,15 €
Ex-dividend date
24 հնս, 2026 թ.
52-wk high
29,25 €
52-wk low
16,38 €
EPS
-0,03 €
Shares outstanding
11,96 մլն
No. of employees
1 հզր
Open
23,15 €
High
23,15 €
Low
23,15 €
Mkt. cap
288,18 մլն
Avg. vol.
51,00
Volume
0,00
Dividend
2,59%
Quarterly dividend
0,15 €
Ex-dividend date
24 հնս, 2026 թ.
52-wk high
29,25 €
52-wk low
16,38 €
EPS
-0,03 €
Shares outstanding
11,96 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
ad-hoc-news.de
·
14 ժամ առաջ
mwb research downgraded Stratec stock to Sell at EUR 21.00 target
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics.
As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE